IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. A special focus of the journal is the publication of works on: (a) Experimental development and application of new diagnostic procedures; (b) Pharmacological and toxicological evaluation of new drugs and drug combinations; (c) Clinical trials; (d) Development and characterization of models of biomedical research.
IN VIVO appears online since January 2009 with the Stanford University HighWire Press.
Special issues presenting the proceedings or/and abstracts of meetings, or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.
The principal aim of IN VIVO is to provide prompt publication of accepted articles, generally within 1-2 months from final acceptance.
IN VIVO supports (a) the aims and research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.
IN VIVO is published bimonthly online-only and open access from January 2017. Each annual volume contains six issues and index.
Articles in IN VIVO are regularly indexed in bibliographic services including PubMed, Index Medicus, MEDLINE, Biological Abstracts, BIOSIS, Chemical Abstracts, Excerpta Medica, CANCER-LIT Database, University of Sheffield Biomedical Information Service (SUBIS), Current Clinical Cancer, AIDS Abstracts, Progress in Paliative Care, Update-Research Information Systems Inc., Inpharma-Reactions Datastar, BRS), Reference Update (I.S.I.), Research Alert (I.S.I.), BioBase, MedBase, Investigational Drugs Database, VINITI Abstracts, PubsHub, Sociedad Iberoamericana de Información Cientifica (SIIC) Databases, Google Scholar.